People

Timothy Cardozo
Timothy Cardozo, MD-PhD
NYU Langone Health, NYU School of Medicine - Associate Professor
Education
MD, NYU School of Medicine
PhD, New York University
Research Interests
Combined cocaine and HIV vaccine, HIV vaccine design, Development of inhibitors for undruggable or yet-to-be drugged targets, Historeceptomics informatics for mechanism of action elucidation
BIO
Timothy Cardozo is Associate Professor of Biochemistry and Molecular Pharmacology at New York University School of Medicine within NYU Langone Health. He leads a laboratory conducting research focused on 3D-structure based rational drug design, molecular engineering, cheminformatics and bioinformatics. These methods are applied to a variety of public health problems, including substance abuse, infectious diseases, cancer and neuropsychiatric disorders. The laboratory is supported by grants from several funding agencies, including from the National Institutes of Health (NIH). A major source of funding has been innovation and investigator programs at the NIH, which have awarded Dr. Cardozo a New Innovator (DP2) award, NIDA Avant-Garde Award for HIV/AIDS Research (DP1), an American Recovery and Reinvestment Act (ARRA) Grand Opportunities (GO) award (RC2) and a Highly Innovative Tactics to Interrupt Transmission of HIV award (R01). Dr. Cardozo was trained in the Medical Scientist Training Program at NYU School of Medicine to receive his MD and PhD degrees.  He has been a faculty member at NYU School of Medicine since 2005.
Projects
Principal Investigator, Combined Cocaine and HIV Vaccine. Completed
Principal Investigator, Epitope Optimization for Heterologous Prime-Boost HIV Vaccines. Completed
Publications

Recent

Aiyegbo MS, Shmelkov E, Dominguez L, Goger M, Battacharya S, deCamp AC, Gilbert PB, Berman PW, Cardozo T (2017).
Peptide targeted by human antibodies associated with HIV vaccine-associated protection assumes a dynamic alpha-helical structure
PLoS One, 12 (1), e0170530. doi: 10.1371/journal.pone.0170530. PMCID: PMC5249078.

Shmelkov E, Nadas A, Cardozo T (2014).
Could vaccination with AIDSVAX immunogens have resulted in antibody-dependent enhancement of HIV infection in human subjects?
Human Vaccines and Immunotherapeutics, 10 (10), 3013-3016. doi: 10.4161/21645515.2014.972148. PMCID: PMC5443089.

Cardozo T, Wang S, Jiang X, Kong XP, Hioe C, Krachmarov C (2014).
Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes
Vaccine, 32 (39), 4916-4924. doi: 10.1016/j.vaccine.2014.07.026. PMCID: PMC4138239.

Shmelkov E, Grigoryan A, Krachmarov C, Abagyan R, Cardozo T (2014).
Sequence-conserved and antibody-accessible sites in the V1V2 domain of HIV-1 gp120 envelope protein
AIDS Research and Human Retroviruses, 30 (9), 927-931. doi: 10.1089/AID.2014.0034. PMCID: PMC4151074.

Shmelkov E, Krachmarov C, Grigoryan AV, Pinter A, Statnikov A, Cardozo T (2014).
Computational prediction of neutralization epitopes targeted by human anti-V3 HIV monoclonal antibodies
PLoS One, 9 (2), e89987. doi: 10.1371/journal.pone.0089987. PMCID: PMC3934971.

Dr. Cardozo's MyBibliography Profile
Selected Press